Testosterone subcutaneous implants are now listed in MIMS.
The 100mg and 200mg implants are indicated for primary and secondary hypogonadism in males. Implants should be inserted into an area where there is relatively little movement or blood supply, such as the lower abdominal wall or buttock.
The recommended dose is 100-600mg. In most hypogonadal men a dose of 600mg maintains plasma testosterone levels within the normal physiological range for 4–5 months.
Further information: MSD